New Horizons in Pharmaceutical Technology

Duane M. Kirking

The ANNALS of the American Academy of Political and Social Science, 1983, vol. 468, issue 1, 182-195

Abstract: The benefits they provide have contributed toward making drugs the most commonly used treatment modality. Although drugs account for less than 10 percent of all health care expenditures, their total costs can be substantial when one considers the impact of adverse effects as well as the problems resulting from misprescribing and misuse. The 1980s will see the introduction of a large number and variety of new drugs and new ways of delivering drugs to the body. The goals of these developments include increased effectiveness, decreased seriousness and frequency of adverse effects, and less complicated dosing regimes. This new technology raises questions regarding the optimal prescribing, distribution, financing, and use of these new drugs. It is also important to consider what actions should be taken to assure that continued growth in drug technology will occur and that this growth be directed toward the development of drugs that offer significant advantages over existing therapies. Rational policy must consider not only the costs of drugs themselves but also the potential for drugs to reduce the overall cost of health care.

Date: 1983
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0002716283468001012 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:anname:v:468:y:1983:i:1:p:182-195

DOI: 10.1177/0002716283468001012

Access Statistics for this article

More articles in The ANNALS of the American Academy of Political and Social Science
Bibliographic data for series maintained by SAGE Publications ().